[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Zhou, H., Gou, H., Zong, J., et al. (2014) ATF3 Regulates Multiple Tar-gets and May Play a Dual Role in Cardiac Hypertrophy and Injury. International Journal of Cardiology, 174, 838-839.
https://doi.org/10.1016/j.ijcard.2014.04.160
|
[3]
|
Rea, D. (2015) Management of Adverse Events Associated with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Annals of Hematology, 94, S149-S158. https://doi.org/10.1007/s00277-015-2318-y
|
[4]
|
Hai, T.W., Liu, F., Coukos, W.J., et al. (1989) Transcription Fac-tor ATF cDNA Clones: An Extensive Family of Leucine Zipper Proteins Able to Selectively Form DNA-Binding Het-erodimers. Genes & Development, 3, 2083-2090.
https://doi.org/10.1101/gad.3.12b.2083
|
[5]
|
Hai, T., Wolford, C.C. and Chang, Y.S. (2010) ATF3, a Hub of the Cellular Adaptive-Response Network, in the Pathogenesis of Diseases: Is Modulation of Inflammation a Unifying Com-ponent? Gene Expression, 15, 1-11.
https://doi.org/10.3727/105221610X12819686555015
|
[6]
|
Rohini, M., Haritha, M.A. and Selvamuruganel, N. (2018) Role of Activating Transcription Factor 3 and Its Interacting Proteins under Physiological and Pathological Condi-tions. International Journal of Biological Macromolecules, 120, 310-317. https://doi.org/10.1016/j.ijbiomac.2018.08.107
|
[7]
|
Thompson, M.R., Xu, D. and Williams, B.R. (2009) ATF3 Transcription Factor and Its Emerging Roles in Immunity and Cancer. Molecular Medicine (Berl), 87, 1053-1060. https://doi.org/10.1007/s00109-009-0520-x
|
[8]
|
Yin, X., Dewille, J.W. and Hai, T. (2008) A Potential Dichoto-mous Role of ATF3, an Adaptive-Response Gene, in Cancer Development. Oncogene, 27, 2118-2127. https://doi.org/10.1038/sj.onc.1210861
|
[9]
|
Yin, X., Wolford, C.C., Chang, Y.S., et al. (2010) ATF3, an Adap-tive-Response Gene, Enhances TGF {beta} Signaling and Cancer-Initiating Cell Features in Breast Cancer Cells. Journal of Cell Science, 123, 3558-3565.
https://doi.org/10.1242/jcs.064915
|
[10]
|
Rohini, M., Arumugam, B., Vairamani, M., et al. (2019) Stimulation of ATF3 Interaction with Smad4 via TGF-β1 for Matrix Metalloproteinase 13 Gene Activation in Human Breast Cancer Cells. International Journal of Biological Macromolecules, 134, 954-961. https://doi.org/10.1016/j.ijbiomac.2019.05.062
|
[11]
|
Yan, L., Della, L., Powell, K.L., et al. (2011) Activation of the Canonical Wnt/β-Catenin Pathway in ATF3-Induced Mammary Tumors. PLOS ONE, 6, e16515. https://doi.org/10.1371/journal.pone.0016515
|
[12]
|
Li, L., Sun, R.M. and Jiang, G.Q. (2020) ATF3 Demethylation Promotes the Transcription of ARL4C, Which Acts as a Tumor Suppressor in Human Breast Cancer. OncoTargets and Therapy, 13, 3467-3476.
https://doi.org/10.2147/OTT.S243632
|
[13]
|
Muller, H.M., Widschwendter, A., Fiegl, H., et al. (2003) DNA Meth-ylation in Serum of Breast Cancer Patients: An Independent Prognostic Marker. Cancer Research, 63, 7641-7645.
|
[14]
|
Pelzer, A.E., Bektic, J., Haag, P., et al. (2006) The Expression of Transcription Factor Activating Transcription Factor 3 in the Human Prostate and Its Regulation by Androgen in Prostate Cancer. Urology, 175, 1517-1522.
https://doi.org/10.1016/S0022-5347(05)00651-8
|
[15]
|
Wang, C.M. and Yang, W.H. (2013) Loss of SUMOylation on ATF3 Inhibits Proliferation of Prostate Cancer Cells by Modulating CCND1/2 Activity. International Journal of Mo-lecular Sciences, 14, 8367-8380.
https://doi.org/10.3390/ijms14048367
|
[16]
|
Bandyopadhyay, S., Wang, Y., Zhan, R., et al. (2006) The Tumor Me-tastasis Suppressor Gene Drg-1 Down-Regulates the Expression of Activating Transcription Factor 3 in Prostate Cancer. Cancer Research, 66, 11983-11990.
https://doi.org/10.1158/0008-5472.CAN-06-0943
|
[17]
|
Huang, X., Li, X. and Guo, B. (2008) KLF6 Induces Apoptosis in Prostate Cancer Cells through Up-Regulation of ATF3. Biological Chemistry, 283, 29795-29801. https://doi.org/10.1074/jbc.M802515200
|
[18]
|
Mollinedo, F. and Gajate, C. (2021) Mitochondrial Targeting In-volving Cholesterol-Rich Lipid Rafts in the Mechanism of Action of the Antitumor Ether Lipid and Alkylphospholipid Analog Edelfosine. Pharmaceutics, 13, 763.
https://doi.org/10.3390/pharmaceutics13050763
|
[19]
|
Udayakumar, T.S., Stoyanova, R., Shareef, M.M., et al. (2016) Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting An-drogen Receptor Activity. Molecular Cancer Therapeutics, 15, 1353-1363. https://doi.org/10.1158/1535-7163.MCT-15-0332
|
[20]
|
Wang, H., Jiang, M., Cui, H., et al. (2012) The Stress Re-sponse Mediator ATF3 Represses Androgen Signaling by Binding the Androgen Receptor. Molecular and Cellular Bi-ology, 32, 3190-3202.
https://doi.org/10.1128/MCB.00159-12
|
[21]
|
Li, X., Zang, S., Yu, Z., et al. (2014) Low Expression of Activating Transcription Factor 3 in Human Hepatocellular Carcinoma and Its Clinicopathological Significance. Pathology Research and Practice, 210, 477-481.
https://doi.org/10.1016/j.prp.2014.03.013
|
[22]
|
Li, X., Zang, S., Cheng, H., et al. (2019) Overexpression of Acti-vating Transcription Factor 3 Exerts Suppressive Effects in HepG2 Cells. Molecular Medicine Reports, 19, 869-876. https://doi.org/10.3892/mmr.2018.9707
|
[23]
|
Chen, C., Ge, C., Liu, Z., et al. (2018) ATF3 Inhibits the Tumorigen-esis and Progression of Hepatocellular Carcinoma Cells via Upregulation of CYR61 Expression. Journal of Experimental & Clinical Cancer Research, 37, 263.
https://doi.org/10.1186/s13046-018-0919-8
|
[24]
|
Germain, C., Niknejad, N., Ma, L., et al. (2010) Cisplatin Induces Cytotoxicity through the Mitogen-Activated Protein Kinase Pathways and Activating Transcription Factor 3. Neoplasia, 12, 527-538. https://doi.org/10.1593/neo.92048
|
[25]
|
Shen, J., Lin, H., Li, G., et al. (2016) TR4 Nuclear Receptor Enhances the Cisplatin Chemo-Sensitivity via Altering the ATF3 Expression to Better Suppress HCC Cell Growth. On-cotarget, 7, 32088-32099.
https://doi.org/10.18632/oncotarget.8525
|
[26]
|
Xiang, D., Yuan, Y., Chen, L., et al. (2015) Niclosamide, an An-ti-Helminthic Molecule, Downregulates the Retroviral Oncoprotein Tax and Pro-Survival Bcl-2 Proteins in HTLV-1-Transformed T Lymphocytes. Biochemical and Biophysical Research Communications, 464, 221-228. https://doi.org/10.1016/j.bbrc.2015.06.120
|
[27]
|
Weng, S., Zhou, L., Deng, Q., et al. (2016) Niclosamide Induced Cell Apoptosis via Upregulation of ATF3 and Activation of PERK in Hepatocellular Carcinoma Cells. BMC Gastroen-terology, 16, 25.
https://doi.org/10.1186/s12876-016-0442-3
|
[28]
|
Li, L., Song, S., Fang, X., et al. (2021) Role of ATF3 as a Prog-nostic Biomarker and Correlation of ATF3 Expression with Macrophage Infiltration in Hepatocellular Carcinoma. BMC Medical Genomics, 14, Article No. 8.
https://doi.org/10.1186/s12920-020-00852-4
|
[29]
|
Hackl, C., Lang, S.A., Moser, C., et al. (2010) Activating Tran-scription Factor-3 (ATF3) Functions as a Tumor Suppressor in Colon Cancer and Is Up-Regulated upon Heat-Shock Protein 90 (Hsp90) Inhibition. BMC Cancer, 10, Article No. 668. https://doi.org/10.1186/1471-2407-10-668
|
[30]
|
Inoue, M., Uchida, Y., Edagawa, M., et al. (2018) The Stress Re-sponse Gene ATF3 Is a Direct Target of the Wnt/β-Catenin Pathway and Inhibits the Invasion and Migration of HCT116 Human Colorectal Cancer Cells. PLOS ONE, 13, e0194160. https://doi.org/10.1371/journal.pone.0194160
|
[31]
|
袁明, 张永盟, 张姗姗, 等. ATF3在结肠癌组织中表达及其对HCT116细胞增殖和迁移影响机制探讨[J]. 中华肿瘤防治杂志, 2018, 25(2): 106-111.
|
[32]
|
Bian, J., Dannappel, M., Wan, C., et al. (2020) Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer. Cells, 9, 2125. https://doi.org/10.3390/cells9092125
|
[33]
|
Song, H.M., Park, G.H., Eo, H.J., et al. (2016) Naringenin-Mediated ATF3 Expression Contributes to Apoptosis in Human Colon Cancer. Biomolecules & Therapeutics (Seoul), 24, 140-146.
https://doi.org/10.4062/biomolther.2015.109
|
[34]
|
Qu, L., Liu, F.X., Cao, X.C., et al. (2014) Activation of the Apoptosis Signal-Regulating Kinase 1/c-Jun N-Terminal Kinase Pathway Is Involved in the Casticin-Induced Apoptosis of Colon Cancer Cells. Experimental and Therapeutic Medicine, 8, 1494-1500. https://doi.org/10.3892/etm.2014.1934
|
[35]
|
Song, H.M., Park, G.H., Koo, J.S., et al. (2017) Vitex Rotundifolia Fruit Extract Induces Apoptosis through the Downregulation of ATF3-Mediated Bcl-2 Expression in Human Colorectal Cancer Cells. The American Journal of Chinese Medicine, 45, 901-915. https://doi.org/10.1142/S0192415X17500483
|
[36]
|
Wu, Z.Y., Wei, Z.M., Sun, S.J., et al. (2014) Activating Tran-scription Factor 3 Promotes Colon Cancer Metastasis. Tumor Biology, 35, 8329-8334. https://doi.org/10.1007/s13277-014-2044-4
|
[37]
|
Shi, B., Yan, W., Liu, G., et al. (2018) MicroRNA-488 Inhibits Tongue Squamous Carcinoma Cell Invasion and EMT by Directly Targeting ATF3. Cellular & Molecular Biology Let-ters, 23, 28. https://doi.org/10.1186/s11658-018-0094-0
|
[38]
|
Hu, Y.T., Li, X.X. and Zeng, L.W. (2019) Circ_0001742 Promotes Tongue Squamous Cell Carcinoma Progression via miR-431-5p/ATF3 Axis. European Review for Medical and Pharmacological Sciences, 23, 10300-10312.
|
[39]
|
Xu, L., Zu, T., Li, T., et al. (2021) ATF3 Downmodulates Its New Targets IFI6 and IFI27 to Suppress the Growth and Migration of Tongue Squamous Cell Car-cinoma Cells. PLOS Genetics, 17, e1009283.
https://doi.org/10.1371/journal.pgen.1009283
|
[40]
|
Huang, C., Chen, R., Zheng, F., et al. (2021) Inhibitory Role of ATF3 in Gastric Cancer Progression through Regulating Cell EMT and Stemness. Cancer Cell International, 21, 127. https://doi.org/10.1186/s12935-021-01828-9
|
[41]
|
Wang, F., Li, J., Wang, H., et al. (2020) Activating Transcription Factor 3 Inhibits Endometrial Carcinoma Aggressiveness via JunB Suppression. International Journal of Oncology, 57, 707-720. https://doi.org/10.3892/ijo.2020.5084
|
[42]
|
Janz, M., Hummel, M., Truss, M., et al. (2006) Classical Hodgkin Lymphoma Is Characterized by High Constitutive Expression of Activating Transcription Factor 3 (ATF3), Which Promotes Viability of Hodgkin/Reed-Sternberg Cells. Blood, 107, 2536-2539. https://doi.org/10.1182/blood-2005-07-2694
|
[43]
|
Guenzle, J., Wolf, L., Garrelfs, N.W., et al. (2017) ATF3 Re-duces Migration Capacity by Regulation of Matrix Metalloproteinases via NFκB and STAT3 Inhibition in Glioblastoma. Cell Death Discovery, 3, Article No. 17006.
https://doi.org/10.1038/cddiscovery.2017.6
|